A follow-up study on men tested for BRCA1/BRCA2 mutations: Impacts and coping processes

Shoshana Shiloh, Efrat Dagan, Irit Friedman, Natalie Blank, Eitan Friedman

Research output: Contribution to journalArticlepeer-review

Abstract

Objective The objective of this study was to examine cognitive, emotional, and behavioral impacts of testing for germline mutations in breast/ovarian cancer-associated genes (BRCA1/BRCA2) among men who undergo genetic testing. Methods A cross-sectional study compared 51 mutation carriers with 30 men who tested negative for the mutations in both genes. Telephone interviews were conducted with all participants at a median of 4 years after disclosure of test results in a genetic counseling context. Testing-related distress, cancer risk perceptions, perceived behavioral changes following testing, and perceptions of breast cancer were measured using standard questionnaires. Results Up to 4 years postgenetic testing, 48% of those who tested positively report that the test increased their perceptions of risk, and 74% of them increased surveillance for cancer. Men who had been tested as non-carriers did not report increased perceived risk (0%) and relatively few increased surveillance (31%). Carriers were significantly more distressed from testing, perceived breast cancer as having less consequences and emotional effects on the patient, and as being more treatable than non-carriers. Conclusions These results have implications with regard to the Self Regulatory Theory. They show that (i) illness representations are affected by fear-arousing health information; (ii) risk perceptions elicit health behaviors; and (iii) men tested for BRCA mutations have specific concerns that should be attended to.

Original languageEnglish
Pages (from-to)417-425
Number of pages9
JournalPsycho-Oncology
Volume22
Issue number2
DOIs
StatePublished - Feb 2013

Keywords

  • BRCA mutations
  • breast cancer
  • coping
  • genetics
  • men
  • oncology

Fingerprint

Dive into the research topics of 'A follow-up study on men tested for BRCA1/BRCA2 mutations: Impacts and coping processes'. Together they form a unique fingerprint.

Cite this